Press release
Global Pulmonary Arterial Hypertension (PAH) Medicine Market to 2025 | Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, GlaxoSmithKline, Pfizer
Market Research Hub
Get Sample Copy of This Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2274977
The global Pulmonary Arterial Hypertension (PAH) Medicine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pulmonary Arterial Hypertension (PAH) Medicine market based on company, product type, end user and key regions.
This report studies the global market size of Pulmonary Arterial Hypertension (PAH) Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pulmonary Arterial Hypertension (PAH) Medicine in these regions.
This research report categorizes the global Pulmonary Arterial Hypertension (PAH) Medicine market by top players/brands, region, type and end user. This report also studies the global Pulmonary Arterial Hypertension (PAH) Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Actelion Pharmaceuticals
Gilead Sciences
United Therapeutics Corporation
GlaxoSmithKline
Pfizer
Bayer HealthCare
Arena Pharmaceuticals
Market size by Product
Endothelin Receptor Antagonists (ERA)
Prostacyclin And Prostacyclin Analogs
Phosphodiesterase 5 (PDE-5)
Soluble Guanylate Cyclase (SGC) Stimulators
Market size by End User
Secondary Pulmonary Hypertension (SPH)
Primary Pulmonary Hypertension (PPH)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
BROWSE Full Report NOW @ https://www.marketresearchhub.com/report/global-pulmonary-arterial-hypertension-pah-medicine-market-insights-forecast-to-2025-report.html
Table of Contents
1 Study Coverage
1.1 Pulmonary Arterial Hypertension (PAH) Medicine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Product
1.4.2 Endothelin Receptor Antagonists (ERA)
1.4.3 Prostacyclin And Prostacyclin Analogs
1.4.4 Phosphodiesterase 5 (PDE-5)
1.4.5 Soluble Guanylate Cyclase (SGC) Stimulators
1.5 Market by End User
1.5.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by End User
1.5.2 Secondary Pulmonary Hypertension (SPH)
1.5.3 Primary Pulmonary Hypertension (PPH)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size
2.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue 2014-2025
2.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales 2014-2025
2.2 Pulmonary Arterial Hypertension (PAH) Medicine Growth Rate by Regions
2.2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Sales by Regions
2.2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pulmonary Arterial Hypertension (PAH) Medicine Sales by Manufacturers
3.1.1 Pulmonary Arterial Hypertension (PAH) Medicine Sales by Manufacturers
3.1.2 Pulmonary Arterial Hypertension (PAH) Medicine Sales Market Share by Manufacturers
3.1.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Manufacturers
3.2.1 Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Manufacturers (2014-2019)
3.2.2 Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Manufacturers (2014-2019)
3.3 Pulmonary Arterial Hypertension (PAH) Medicine Price by Manufacturers
3.4 Pulmonary Arterial Hypertension (PAH) Medicine Manufacturing Base Distribution, Product Types
3.4.1 Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Pulmonary Arterial Hypertension (PAH) Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
More Information………@@@
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pulmonary Arterial Hypertension (PAH) Medicine Market to 2025 | Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, GlaxoSmithKline, Pfizer here
News-ID: 1723112 • Views: …
More Releases from Market Research Hub
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the…
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section…
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the…
More Releases for Pulmonary
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape.
Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood…
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot
The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
